1. Home
  2. BBW vs BNTC Comparison

BBW vs BNTC Comparison

Compare BBW & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BBW

Build-A-Bear Workshop Inc.

HOLD

Current Price

$36.88

Market Cap

444.3M

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$13.50

Market Cap

454.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBW
BNTC
Founded
1997
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
444.3M
454.2M
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
BBW
BNTC
Price
$36.88
$13.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
3
Target Price
$67.71
$27.67
AVG Volume (30 Days)
289.2K
68.2K
Earning Date
05-28-2026
05-14-2026
Dividend Yield
2.51%
N/A
EPS Growth
5.00
80.94
EPS
1.45
N/A
Revenue
$357,866,000.00
N/A
Revenue This Year
$5.63
N/A
Revenue Next Year
$4.62
N/A
P/E Ratio
$23.94
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.35
$9.85
52 Week High
$75.77
$16.76

Technical Indicators

Market Signals
Indicator
BBW
BNTC
Relative Strength Index (RSI) 55.18 61.93
Support Level $33.50 $11.35
Resistance Level $36.06 $13.48
Average True Range (ATR) 1.22 0.69
MACD 0.05 0.09
Stochastic Oscillator 55.05 91.24

Price Performance

Historical Comparison
BBW
BNTC

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments: Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, U.K., Ireland, and two e-commerce sites, the international franchising segment includes royalties and product and fixture sales from other international operations under franchise agreements, and the commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: